Abstract
Ibrutinib in Combination with Ifosfamide, Etoposide, and Rituximab Followed by Ibrutinib Maintenance Therapy in Patients with R/R‐PCNSL: A Multicenter Phase II Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have